Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: Ampersand, Arbor & more
Welcome to Fierce Biotech's Fundraising Tracker for 2025.
Gabrielle Masson
,
Darren Incorvaia
Mar 24, 2025 7:00am
Investment firm secures $250M to help fund dementia drug R&D
Mar 20, 2025 2:53pm
Arbor sails into rocky gene editing waters with $74M
Mar 18, 2025 6:30am
Curevo clinches $110M, nabs Moncef Slaoui to lead board
Mar 17, 2025 10:44am
Latigo saddles up with $150M to advance non-opioid pain assets
Mar 17, 2025 5:00am
George Church spinout restructures, considers strategic options
Mar 13, 2025 2:00pm